Mentor Medical Device Company Intelligence Report

Table of Contents

• EXECUTIVE SUMMARY
• OVERVIEW
• Operating Results
• Fig.1: Total Revenue, 1995-2006 (US$ million)
• Operating Results by Business Segment, 2004-2006 (US$ million)*
• Fig.2: Percentage of Revenue by Business Segment, 2006*
• Recent Key Events
• STRATEGIC FOCUS
• PRODUCT PORTFOLIO AND R&D
• Aesthetic and General Surgery Sales by Product Type, 2004-2006 (US$ million)*
• Fig.3: Percentage of Aesthetic and General Surgery Sales by Product, 2006
• New Product Approvals, 2005-2006
• Top 5 Cosmetic Surgery Procedures, 2005*
• Top 5 Non-Surgical Cosmetic Procedures, 2005*
• FACIAL AESTHETICS
• Fig.4: US Dermal Filler Market, 2002-2008E (US$ million)
• Puragen and Puragen Plus
• BREAST IMPLANTS
• Silicone Gel Implants
• Contour Profile Gel Implants
• US Clinical Trials
• Memory Gel Round Silicone Gel Breast Implant Trial
• Contour Profile Implant Trial
• National Cancer Institute Study
• Saline Breast Implants
• Moderate Plus Profile
• Shaped Implants
• Round Implants
• Becker Adjustable Breast Implants/Expander
• Spectrum Adjustable Breast Implants
• Tissue Expanders
• Post-Surgical Garments
• BODY CONTOURING AND LIPOSUCTION DEVICES
• ActiPatch
• Ultrasonic Systems
• Aspirators and Accessories
• Infiltration
• Cannulae and Dissectors
• Foam, Tape and Cold Therapy Products
• Alpha Infusion Pumps
• Bleph Instrumentation
• Eye Shields and Splints
• PLASTIC SURGERY SOFTWARE SOLUTIONS
• Inform&Enhance Software
• Insched
• Inform&Consent
• MD Tracker
• ControlRoom
• RESEARCH AND DEVELOPMENT
• Research Establishments
• Research Projects
• Botulinum Toxin
• INTERNATIONAL ACTIVITIES
• Revenue from Continuing Operations by Region, 2004-2006 (US$ million)*
• Long-lived Assets from Continuing Operations by Region, 2004-2006 (US$ million)*
• Fig.5: Percentage of Revenue from Continuing Operations by Region, 2006*
• Fig.6: Long-lived Assets from Continuing Operations by Region, 2006*
• Fig.7: Revenue from Continuing Operations by Region, 2004-2006 (US$ million)
• Fig.8: Long-lived Assets from Continuing Operations by Region, 2004-2006 (US$ million)
• NORTH AMERICA
• United States
• Canada
• OTHER COUNTRIES
• The Netherlands
• United Kingdom
• Global Manufacturing Facilities

APPENDICES

• APPENDIX 1 - FINANCIAL INDICATORS
• FINANCIAL INDICATORS
• APPENDIX 2 - KEY CORPORATE EVENTS
• APPENDIX 3 - MERGERS AND ACQUISITIONS
• Key Mergers & Acquisitions
• Inform Solutions
• AMI' s Uterine Disorder Products
• A-Life
• Rights to ObTape
• Mills Biopharmaceuticals
• Portex' s Urology and Ostomy Business
• Byron Medical
• ProSurg Stress Incontinence Product
• Porges
• DesChutes Medical Products' Pessary Line
• South Bay Medical
• Sierra Laboratories
• Needles & Infusion Technologies' Product Line
• Boston Pacific Medical Devices
• Teknar
• Mentor O&O
• APPENDIX 4 - DIVESTITURES
• Surgical Urology and Clinical and Consumer Healthcare Divisions
• UK Urisheath Business and US Manufacturing Assets
• North American Scientific
• Ophthalmics Phaco Cataract Removal Business
• Ophthalmology Division - Certain Assets
• Intraocular Lens Business
• APPENDIX 5 - AGREEMENTS
• Key Agreements
• Tutogen Medical
• Coloplast
• Niadyne
• BioElectronics
• Wisconsin Alumni Research Foundation (WARF)
• Misonix
• APPENDIX 6 - LITIGATION
• PTF Royalty Partnership

Index of Tables

• Operating Results by Business Segment, 2004-2006 (US$ million)*
• Recent Key Events
• Aesthetic and General Surgery Sales by Product Type, 2004-2006 (US$ million)*
• New Product Approvals, 2005-2006
• Top 5 Cosmetic Surgery Procedures, 2005*
• Top 5 Non-Surgical Cosmetic Procedures, 2005*
• Revenue from Continuing Operations by Region, 2004-2006 (US$ million)*
• Long-lived Assets from Continuing Operations by Region, 2004-2006 (US$ million)*
• Global Manufacturing Facilities
• FINANCIAL INDICATORS
• Key Mergers & Acquisitions
• Key Agreements

Index of Charts

• Fig.1: Total Revenue, 1995-2006 (US$ million)
• Fig.2: Percentage of Revenue by Business Segment, 2006*
• Fig.3: Percentage of Aesthetic and General Surgery Sales by Product, 2006
• Fig.4: US Dermal Filler Market, 2002-2008E (US$ million)
• Fig.5: Percentage of Revenue from Continuing Operations by Region, 2006*
• Fig.6: Long-lived Assets from Continuing Operations by Region, 2006*
• Fig.7: Revenue from Continuing Operations by Region, 2004-2006 (US$ million)
• Fig.8: Long-lived Assets from Continuing Operations by Region, 2004-2006 (US$ million)